No Data
No Data
Pulse Biosciences Insiders Up US$3.3m On US$9.77m Investment
Insiders who bought Pulse Biosciences, Inc. (NASDAQ:PLSE) stock lover the last 12 months are probably not as affected by last week's 16% loss. After accounting for the recent loss, the US$9.77m worth
Pulse Biosciences, Inc. Announces Commencement of Rights Offering
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of SentinelOne, Inc. (NYSE:S) shares fell sharply during Friday's session after the company posted mixed first-quarter results.SentinelOne reported quarterly losses of 23 cents per share, which
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersNovo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 69.6% to $0.77 during Friday's pre-market session. The company's market cap stands at $14.5 million. Adaptimmune Therapeutics (NASD
President & CEO of Pulse Biosciences Burke Barrett Buys More Stock
Pulse Biosciences(PLSE.US) Officer Buys US$85,600 in Common Stock
$Pulse Biosciences(PLSE.US)$ Officer Barrett Burke Thomas purchased 10,000 shares of common stock on May 20, 2024 at an average price of $8.56 for a total value of $85,600.Source: Announcement(one of
No Data